Paul S. Hoffman
Professor Emeritus, Medicine- Infectious Diseases and International Health
Charlottesville, VA 22908
Bio & Overview
Helicobacter pylori colonizes the gastric mucosa of humans, a niche that is hostile to other microbes. In the absence of niche competition, how much regulation does a microbe need? We and others have shown that H. pylori contains few transcription factors and that regulation is not a strong on/off, as seen with regulators in E. coli. There are two essential transcription factors ArsR and HP1043 and while ArsR is associated with responses to acid, the function of HP1043 is unknown. Our studies connect HP1043 to oxidative stress and to redox toxicity of prodrugs like metronidazole. Using proteomics and qPCR techniques, we have identified members of the HP1043 regulon using a mutant form of the protein. We have also identified a non-coding regulatory RNA upstream of HP1043 that cooperates with HP1043 in regulating many genes of the regulon. These ncRNAs are abundant in H. pylori and appear to be important in modulating expression of many gene systems.
My laboratory has been involved in the study of drug resistance and in the development of new genomic/ bioinformatic based strategies for identifying new microbial targets to aid the discovery of new therapeutics. We have synthesized a novel antibiotic Amixicile that is a potent inhibitor of pyruvate ferredoxin oxidoreductase (PFOR) and related alpha keto acid decarboxylases common to all strictly anaerobic bacteria, anaerobic human parasites and to microaerobic human pathogens Helicobacter pylori and Campylobacter jejuni. The target is not found in humans or probiotic beneficial microorganisms. Amixicle shows efficacy against Clostridium difficile and Helicobacter pylori in mouse infection models. Related analogues with different chemistries show efficacy against biofilm producing bacteria and against Legionella pneumophila, Bacillus anthracis and MRSA strains of Staphylococcus aureus.
Academic Information
- Department
- Medicine- Infectious Diseases and International Health
- Academic Title
- Professor
Primary Education
- BS, Biology, Virginia Polytechnic Institute and State University, 1972
- MS, Bacteriology, Iowa State University, 1974
- PhD, Microbiology, Virginia Polytechnic Institute and State University, 1977
Other Appointments
- Professor, Microbiology, Immunology, and Cancer Biology
Other Affiliations
- Professor, BIMS
Research Interests
Selected Publications
Cheruvanky A, Stoesser N, Sheppard AE, Crook DW, Hoffman PS, Weddle E, Carroll J, Sifri CD, Chai W, Barry K, Ramakrishnan G, Mathers AJ, Enhanced Klebsiella pneumoniae Carbapenemase Expression from a Novel Tn4401Deletion., 2017; Antimicrobial agents and chemotherapy. 61(6) . PMID: 28373185 | PMCID: PMC5444142
Hutcherson JA, Sinclair KM, Belvin BR, Gui Q, Hoffman PS, Lewis JP, Amixicile, a novel strategy for targeting oral anaerobic pathogens., 2017; Scientific reports. 7(1) 10474. PMID: 28874750 | PMCID: PMC5585216
Qu Y, Olsen JR, Yuan X, Cheng PF, Levesque MP, Brokstad KA, Hoffman PS, Oyan AM, Zhang W, Kalland KH, Ke X, Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer., 2017; Nature chemical biology. 14(1) 94-101. PMID: 29083417
Chahales P, Hoffman PS, Thanassi DG, Nitazoxanide Inhibits Pilus Biogenesis by Interfering with Folding of the Usher Protein in the Outer Membrane., 2016; Antimicrobial agents and chemotherapy. 60(4) 2028-38. PMID: 26824945 | PMCID: PMC4808142
Kennedy AJ, Bruce AM, Gineste C, Ballard TE, Olekhnovich IN, Macdonald TL, Hoffman PS, Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria., 2016; Antimicrobial agents and chemotherapy. 60(7) 3980-7. PMID: 27090174 | PMCID: PMC4914612
Hoffman PS, Bruce AM, Olekhnovich I, Warren CA, Burgess SL, Hontecillas R, Viladomiu M, Bassaganya-Riera J, Guerrant RL, Macdonald TL, Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pylori., 2014; Antimicrobial agents and chemotherapy. 58(8) 4703-12. PMID: 24890599 | PMCID: PMC4136022
Kpadeh ZZ, Day SR, Mills BW, Hoffman PS, Legionella pneumophila utilizes a single-player disulfide-bond oxidoreductase system to manage disulfide bond formation and isomerization., 2014; Molecular microbiology. 95(6) 1054-69. PMID: 25534767 | PMCID: PMC4415175
Olekhnovich IN, Vitko S, Valliere M, Hoffman PS, Response to Metronidazole and Oxidative Stress is Mediated Through Homeostatic Regulator HsrA (HP1043) in Helicobacter pylori., 2013; Journal of bacteriology. () . PMID: 24296668 | PMCID: PMC3911170
Olekhnovich IN, Vitko S, Chertihin O, Hontecillas R, Viladomiu M, Bassaganya-Riera J, Hoffman PS, Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects., 2013; Infection and immunity. 81(5) 1439-49. PMID: 23429531 | PMCID: PMC3647984
Kpadeh ZZ, Jameson-Lee M, Yeh AJ, Chertihin O, Shumilin IA, Dey R, Day SR, Hoffman PS, Disulfide bond oxidoreductase DsbA2 of Legionella pneumophila exhibits protein disulfide isomerase activity., 2013; Journal of bacteriology. 195(8) 1825-33. PMID: 23435972 | PMCID: PMC3624562
Warren CA, van Opstal E, Ballard TE, Kennedy A, Wang X, Riggins M, Olekhnovich I, Warthan M, Kolling GL, Guerrant RL, Macdonald TL, Hoffman PS, Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model., 2012; Antimicrobial agents and chemotherapy. 56(8) 4103-11. PMID: 22585229 | PMCID: PMC3421617
Dey R, Hoffman PS, Glomski IJ, Germination and amplification of anthrax spores by soil-dwelling amoebas., 2012; Applied and environmental microbiology. 78(22) 8075-81. PMID: 22983962 | PMCID: PMC3485947
Martínez-Júlvez M, Rojas AL, Olekhnovich I, Espinosa Angarica V, Hoffman PS, Sancho J, Structure of RdxA--an oxygen-insensitive nitroreductase essential for metronidazole activation in Helicobacter pylori., 2012; The FEBS journal. 279(23) 4306-17. PMID: 23039228 | PMCID: PMC3504637
Warren CA, van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, Guerrant RL, Hoffman PS, Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice., 2012; Antimicrobial agents and chemotherapy. 57(2) 689-96. PMID: 23147742 | PMCID: PMC3553708
Day SR, Sifri CD, Hoffman PS, Infection of nonphagocytic host cells by legionella., 2012; Methods in molecular biology (Clifton, N.J.). 954() 463-78. PMID: 23150414
Jameson-Lee M, Garduño RA, Hoffman PS, DsbA2 (27 kDa Com1-like protein) of Legionella pneumophila catalyses extracytoplasmic disulphide-bond formation in proteins including the Dot/Icm type IV secretion system., 2011; Molecular microbiology. 80(3) 835-52. PMID: 21375592 | PMCID: PMC3086132
Ballard TE, Wang X, Olekhnovich I, Koerner T, Seymour C, Salamoun J, Warthan M, Hoffman PS, Macdonald TL, Synthesis and antimicrobial evaluation of nitazoxanide-based analogues: identification of selective and broad spectrum activity., 2011; ChemMedChem. 6(2) 362-77. PMID: 21275058 | PMCID: PMC3089805
Costa LB, JohnBull EA, Reeves JT, Sevilleja JE, Freire RS, Hoffman PS, Lima AA, Oriá RB, Roche JK, Guerrant RL, Warren CA, Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model., 2011; The Journal of parasitology. 97(6) 1113-20. PMID: 21711105 | PMCID: PMC3247658